Safety & Packaging

    – HIV type 1
    – HIV type 2
    – HBV Surface Antigen
    – HBV Core Antibody
    – HCV Antibody
    – STS (Syphilis RPR/VDRL)
    – Human T-Lymphotropic Virus 1
    – Human T-Lymphotropic Virus 2
    – HIV-1 RNA NAT
    – HCV RNA NAT
  • Process removes all living components and cell fragments eliminating immunogenicity
  • Bacterial and viral log reduction via Tissue Sterilization Processes
  • Validated, double-sterile barrier packaging
  • Donor and Lot traceability on each label